That's a good sense of the words. How do you put us on a level playing field with the U.S.?
In the U.S., when a generic has passed the science, is proved equivalent, and is safe for health and the environment, there is a form called “Offer to Pay”, and they provide that form to the owner of any compensable data, if there is compensable data. They can enter the market immediately upon completion of that review by the EPA.
What is being suggested in Canada is that we go through a 120-day negotiation period afterwards, and if that doesn't work, another 120 days of binding arbitration.